Semaglutide 40 Units: Dosing Guide for Weight Loss

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling your brain's satiety centers, with clinical trials showing average weight loss of 15-22% at higher maintenance doses. Many patients ask what specific unit counts like 40 units mean for their results, and the answer depends on your individual baseline, genetics, and treatment timeline. PlexusDx provides compounded semaglutide injections tailored to your body's response, starting at just $149 per month regardless of your dose level.

What Does 40 Units of Semaglutide Actually Mean?

Semaglutide is measured in micrograms (mcg), not units—a critical distinction for patients navigating their own research. The term '40 units' sometimes appears in older literature or non-medical contexts, but modern prescribing uses the metric system: doses typically range from 0.25 mcg weekly up to 2.4 mcg weekly for weight management. If you've encountered '40 units' in a discussion, it may refer to an insulin-era measurement system that doesn't apply to modern GLP-1 therapy; your actual semaglutide dose will be prescribed in micrograms and communicated clearly by your PlexusDx provider.

Your starting dose at PlexusDx begins low—often 0.25 mcg weekly—then increases gradually over 4-8 weeks based on how your body responds. This titration approach minimizes nausea and other gastrointestinal side effects while allowing your metabolism to adapt. Most patients reach a maintenance dose between 1.0 and 2.4 mcg weekly, though individual variation is significant and influenced by genetics, weight baseline, and metabolic health.

How Semaglutide Dosing Works in Your Weight Loss Protocol

PlexusDx structures semaglutide treatment as a progressive journey rather than a fixed endpoint. Your dose increases every 4 weeks during the titration phase, and your price stays flat at $149 per month—your dose may need to go up, but your cost won't. This approach ensures you're getting the minimum effective dose for your body, reducing unnecessary side effects while maximizing fat loss and metabolic benefit.

Clinical evidence shows that higher semaglutide doses (2.0-2.4 mcg weekly) produce greater weight loss than lower maintenance doses, but individual response varies dramatically. Some patients achieve their target weight at 1.0 mcg weekly, while others benefit from the full 2.4 mcg dose. PlexusDx monitors your progress through regular check-ins and can adjust your protocol based on your results, appetite suppression level, and tolerability.

Genetic Factors That Shape Your Ideal Semaglutide Dose

Your genetic makeup influences how effectively your body responds to semaglutide, and PlexusDx offers the Precision Peptide Genetic Test to map your individual peptide pathways. Key variants like GLP1R rs6923761 and GIPR rs1800437 directly affect receptor sensitivity, meaning two patients at the same body weight may need very different doses to achieve comparable results. The test analyzes 14 pathways and 150+ genetic insights, revealing your predisposition to GLP-1 response and informing a truly personalized protocol.

Patients with certain FTO and MC4R genetic variants often show enhanced appetite suppression at lower doses, while those with reduced receptor sensitivity may benefit from gradual upward titration toward higher maintenance levels. Adding the Precision Peptide Genetic Test ($99 after your first month of treatment) helps PlexusDx providers fine-tune your semaglutide dose based on biology, not guesswork, accelerating your path to sustainable weight loss.

Managing Expectations: Timeline and Real-World Results

Weight loss on semaglutide follows a predictable but individualized timeline: most patients see modest results in weeks 1-4 (1-3 lbs), accelerating between weeks 5-12 as their dose reaches therapeutic levels. By month three, many patients report losing 5-10% of their starting weight, with continued loss through months 4-6 and plateauing around 6-12 months depending on dose and adherence. Realistic expectations prevent disappointment and help you stay committed through the early weeks when appetite suppression is building.

Your PlexusDx provider discusses realistic outcome ranges based on your baseline weight, metabolic health, and genetics before starting treatment. A patient with a BMI of 35 aiming for a BMI under 25 follows a different timeline than someone with a BMI of 28, and genetic testing can predict which patients typically respond faster. Combining injectable semaglutide ($149/mo starting) with behavior support and consistent monitoring gives you the best foundation for sustained results.

PlexusDx Semaglutide vs. Other GLP-1 Options

PlexusDx offers both compounded semaglutide injection and oral semaglutide, each with distinct advantages. The injection form (starting at $149/mo) has superior bioavailability and faster action, making it ideal for patients who want quick appetite suppression and measurable results within 4-6 weeks. Oral semaglutide ($249/mo) provides convenience for needle-averse patients, though it requires specific timing and an empty stomach for absorption, often resulting in slightly slower weight loss trajectories.

For patients seeking even greater potency, PlexusDx also compounds tirzepatide (a dual GIP/GLP-1 receptor agonist starting at $249/mo injection or $279/mo oral) and GLP-Squared combinations that enhance results for those plateauing on semaglutide alone. All medications come from licensed 503A compounding pharmacies, serve all 50 states without insurance requirements, and are HSA/FSA eligible—ensuring accessibility alongside clinical efficacy. Your PlexusDx provider helps you choose the right compound and delivery method based on your goals, medical history, and preferences.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is a typical semaglutide dose progression at PlexusDx?

PlexusDx patients typically start at 0.25 mcg weekly and increase by 0.25 mcg every 4 weeks (weeks 1-4: 0.25 mcg, weeks 5-8: 0.5 mcg, weeks 9-12: 1.0 mcg) until reaching your target maintenance dose between 1.0-2.4 mcg weekly. Your price remains flat at $149/mo throughout this titration, ensuring you pay the same regardless of dose level.

How much weight can I expect to lose on semaglutide?

Clinical trials show average weight loss of 15-22% of body weight on semaglutide 2.4 mcg weekly over 68 weeks, though individual results vary widely. PlexusDx patients often see 1-3 lbs in the first month, 5-10% body weight loss by month three, and maximum results typically by month 6-12 depending on adherence and genetics.

Can PlexusDx help me find my ideal semaglutide dose?

Yes—PlexusDx providers monitor your progress during regular check-ins and adjust your dose based on appetite suppression, side effects, and weight loss. The optional Precision Peptide Genetic Test ($99 after month one) accelerates this process by revealing your genetic predisposition to GLP-1 response, helping providers target your ideal mainten...

What are the main side effects of semaglutide, and do they decrease with time?

Nausea, vomiting, constipation, and reduced appetite are common early side effects, typically peaking in weeks 2-4 and improving significantly by week 8-12 as your body adapts. Gradual dose titration at PlexusDx minimizes these effects; staying hydrated, eating small frequent meals, and increasing fiber intake helps most patients manage symptoms...

Will the Precision Peptide Genetic Test change my semaglutide dose?

The Precision Peptide Genetic Test may inform your provider's decision about dose timing and maintenance level based on your GLP1R, GIPR, FTO, and MC4R variants. Patients with high-sensitivity variants sometimes reach therapeutic benefit at lower doses, while those with reduced sensitivity may benefit from faster titration toward higher doses—pe...

Navigating Semaglutide Dosing: What 40 Units Means for Your Weight Loss Journey